‘Significant’ Cases of Neurological Disorder Associated With the AstraZeneca Vaccine

‘Significant’ Cases of Neurological Disorder Associated With the AstraZeneca Vaccine
A dose of the AstraZeneca COVID-19 vaccine in a file photograph. Louai Beshara/AFP via Getty Images
|Updated:
0:00

A UK study by University College London has confirmed “small but significant” cases of the serious Guillain-Barre syndrome (GBS), a rare neurological disorder associated with the AstraZeneca vaccine for COVID-19.

The researchers speculate that “the majority or all” of the 121 UK cases of GBS (pdf) in March to April 2021 were associated with first doses of the AstraZeneca vaccine administered in January.
Marina Zhang
Marina Zhang
Author
Marina Zhang is a health reporter for The Epoch Times, based in New York. She covers both health news and in-depth features on emerging health issues. Marina holds a bachelor's degree in biomedicine from the University of Melbourne. Contact her at [email protected].
Related Topics